About Us
Statement of Compliance
[Printable View]
Sterling Institutional Review Board (IRB) is organized and operates in compliance with the U.S. Department of Health and Human Services and U.S. Food and Drug Administration regulations for the protection of human subjects as described in 45 CFR Part 46, 160, 164 and 21 CFR Parts 50, 56, 312 and 812 and adheres to the International Conference on Harmonisation (ICH) Good Clinical Practice (GCP) guidelines.
In accordance with Federal regulations, Sterling IRB has written policies and procedures for the operation of the IRB as described in 45 CFR 46.103(b) (4) and (5), and the FDA guidance for IRBs and Clinical Investigators 1998, Appendix H.
Sterling Institutional Review Board's primary responsibility is to protect the privacy, safety and welfare of the human subject participating in research.
To learn more or if you have any questions, call 1-888-636-1062 (toll-free) or email us.
|
|
|
|
